ResearcherShandong UniversityNo recent work listed
Chunning Zheng
Matched on OpenAlex author ID A5100947444. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2012: 2 papers · 2013: 2 papers
Papers 4
- ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells. Co-author DOI 10.1177/0300060512474128↗
- Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation Co-author DOI 10.1186/1756-9966-32-42↗
- Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. Co-author DOI 10.1186/1756-9966-31-73↗
- Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway. Co-author DOI 10.1186/1756-9966-31-84↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yingsheng Jiang · 4 shared papers, 2012–2013 · strength 0.18
- Paper ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells. DOI 10.1177/0300060512474128↗
- Paper Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation DOI 10.1186/1756-9966-32-42↗
- Paper Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. DOI 10.1186/1756-9966-31-73↗
- Yong Mei Tang · 3 shared papers, 2012–2013 · strength 0.12
- Paper Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation DOI 10.1186/1756-9966-32-42↗
- Paper Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. DOI 10.1186/1756-9966-31-73↗
- Paper Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal path… DOI 10.1186/1756-9966-31-84↗
- Shaochuan Sun · 2 shared papers, 2012–2013 · strength 0.09
- Fenghua Liu · 2 shared papers, 2012–2013 · strength 0.09
- Paper Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation DOI 10.1186/1756-9966-32-42↗
- Paper Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. DOI 10.1186/1756-9966-31-73↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.